The Department of Defense's Defense Logistics Agency (DLA) awarded a $20,799.75 Firm Fixed Price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division to provide PROQUAD VIALS. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract valued up to $16,019.90 to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This Firm Fixed Price contract is for the supply of PROQUAD VIALS and has a period of performance through May 17, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $4,711.62 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of PROQUAD VIALS, a vaccine product, with a period of performance through July 5, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $3,203.98 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) for the supply of PROQUAD VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00, to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of...
The Defense Logistics Agency (DLA) awarded a $14,134.86 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of PROQUAD VIALS. This contract has no set-aside designation and is scheduled for completion by September 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these critical medical supplies to support various government agencies and healthcare programs. The company has been awarded numerous federal contracts by the DLA and...
The Defense Logistics Agency (DLA) awarded a $4,711.62 firm fixed-price delivery order to Amerisourcebergen Drug Corp for the supply of PROQUAD VIALS. The contract has an ultimate completion date of September 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, will provide these medical supplies to support various government agencies and healthcare programs, including military treatment facilities and veterans' hospitals. This delivery order is part of a larger Indefinite Delivery...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,247.58, is for the delivery of PROQUAD VIALS and has an ultimate completion date of January 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,575.60 firm fixed price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product. The contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a $7,022.60 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide pharmaceutical products and medical supplies. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medical commodities to the Department of...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $3,203.98, is for the delivery of PROQUAD VIALS, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price arrangement with no set-aside designation. Amerisourcebergen...